ZA201209240B - Topical ophthalmic suspensions containing tobramyccin and dexamethasone - Google Patents
Topical ophthalmic suspensions containing tobramyccin and dexamethasoneInfo
- Publication number
- ZA201209240B ZA201209240B ZA2012/09240A ZA201209240A ZA201209240B ZA 201209240 B ZA201209240 B ZA 201209240B ZA 2012/09240 A ZA2012/09240 A ZA 2012/09240A ZA 201209240 A ZA201209240 A ZA 201209240A ZA 201209240 B ZA201209240 B ZA 201209240B
- Authority
- ZA
- South Africa
- Prior art keywords
- tobramyccin
- dexamethasone
- suspensions containing
- topical ophthalmic
- ophthalmic suspensions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2010/039618 WO2011162752A1 (en) | 2010-06-23 | 2010-06-23 | Topical ophthalmic suspensions containing tobramycin and dexamethasone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201209240B true ZA201209240B (en) | 2014-02-26 |
Family
ID=44080140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2012/09240A ZA201209240B (en) | 2010-06-23 | 2012-12-06 | Topical ophthalmic suspensions containing tobramyccin and dexamethasone |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2585037A1 (en) |
| JP (1) | JP5728082B2 (en) |
| KR (1) | KR20130094280A (en) |
| CN (1) | CN102946855B (en) |
| AU (1) | AU2010356098B2 (en) |
| BR (1) | BR112012033052A2 (en) |
| CA (1) | CA2801731A1 (en) |
| MX (1) | MX2012015051A (en) |
| WO (1) | WO2011162752A1 (en) |
| ZA (1) | ZA201209240B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201208080D0 (en) * | 2012-05-09 | 2012-06-20 | Norton Healthcare Ltd | Tobramycin formulation |
| JP6527315B2 (en) * | 2014-08-08 | 2019-06-05 | Ｄｓｐ五協フード＆ケミカル株式会社 | Fast-dissolving thickener, thickener for people with dysphagia and dysphagia, food and drink for patients with dysphagia and dysphagia |
| CN109260219B (en) * | 2018-11-30 | 2021-03-09 | 山东省药学科学院 | Articular cavity injection preparation and application thereof |
| IT202000002296A1 (en) * | 2020-02-06 | 2021-08-06 | Sifi Spa | Topical ophthalmic formulations based on xanthan with reduced dosage |
| IT202200000821A1 (en) * | 2022-01-19 | 2023-07-19 | Sifi Spa | TOPICAL OPHTHALMIC FORMULATIONS BASED ON XANTHANE WITH REDUCED DOSAGE |
| CN115006412B (en) * | 2022-05-20 | 2023-11-10 | 北京诺康达医药科技股份有限公司 | Compound tobramycin eye drops and preparation method thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136177A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
| US5149694A (en) | 1988-03-09 | 1992-09-22 | Alcon Laboratories, Inc. | Combination of tobramycin and dexamethasone for topical ophthalmic use |
| EP1348427B1 (en) * | 1997-07-29 | 2008-04-09 | Alcon Laboratories, Inc. | Ophthalmic compositions containing galactomannan polymers and borate |
| US6174524B1 (en) | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| DE69909768T2 (en) * | 1998-04-07 | 2004-06-17 | Alcon Manufacturing Ltd., Fort Worth | XANTHAN GUM CONTAINING YELLOWING OPHTHALMIC COMPOSITIONS |
| PL199321B1 (en) | 2000-07-28 | 2008-09-30 | Alcon Inc | Pharmaceutical compositions containing tobramycin and xanthan gum |
-
2010
- 2010-06-23 KR KR1020137000258A patent/KR20130094280A/en active IP Right Grant
- 2010-06-23 BR BR112012033052A patent/BR112012033052A2/en not_active IP Right Cessation
- 2010-06-23 WO PCT/US2010/039618 patent/WO2011162752A1/en active Application Filing
- 2010-06-23 JP JP2013516553A patent/JP5728082B2/en not_active Expired - Fee Related
- 2010-06-23 CN CN201080067666.9A patent/CN102946855B/en not_active Expired - Fee Related
- 2010-06-23 MX MX2012015051A patent/MX2012015051A/en active IP Right Grant
- 2010-06-23 AU AU2010356098A patent/AU2010356098B2/en not_active Ceased
- 2010-06-23 EP EP10726406.1A patent/EP2585037A1/en not_active Withdrawn
- 2010-06-23 CA CA2801731A patent/CA2801731A1/en not_active Abandoned
-
2012
- 2012-12-06 ZA ZA2012/09240A patent/ZA201209240B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012033052A2 (en) | 2019-09-24 |
| CA2801731A1 (en) | 2011-12-29 |
| JP2013529632A (en) | 2013-07-22 |
| CN102946855A (en) | 2013-02-27 |
| CN102946855B (en) | 2016-01-06 |
| WO2011162752A1 (en) | 2011-12-29 |
| KR20130094280A (en) | 2013-08-23 |
| AU2010356098B2 (en) | 2014-08-14 |
| EP2585037A1 (en) | 2013-05-01 |
| AU2010356098A1 (en) | 2013-01-10 |
| MX2012015051A (en) | 2013-02-15 |
| JP5728082B2 (en) | 2015-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181119T1 (en) | Self-sealing dressing | |
| EP2717931A4 (en) | Dressings and related methods therefor | |
| EP2739695A4 (en) | Adhesives and use thereof | |
| EP2662429A4 (en) | Composition for adhesive hydrogel and use thereof | |
| GB201006323D0 (en) | Leakage-reducing dressing | |
| HK1145255A2 (en) | Health-caring glasses | |
| GB2477264B (en) | Eyeglasses and means for their adjustment | |
| HK1207662A1 (en) | Cell suspension and use thereof | |
| HK1191034A1 (en) | N-carboxyalkyl-auristatins and use thereof n- | |
| EP2566487A4 (en) | Ophthalmic composition | |
| HK1168659A1 (en) | Eyeglass frame and temple | |
| EP2660646A4 (en) | Eyewear | |
| EP2614400A4 (en) | Eyewear with improved fit | |
| EP2605767A4 (en) | Ship1 modulators and related methods | |
| ZA201209240B (en) | Topical ophthalmic suspensions containing tobramyccin and dexamethasone | |
| EP2659903A4 (en) | Nanoemulsion-type ophthalmic composition | |
| EP2602652A4 (en) | Nose pad and eyewear | |
| EP2521938A4 (en) | Eyewear earstem devices and methods | |
| TWM389855U (en) | Eyeglasses structure | |
| GB201018552D0 (en) | Eyeglasses | |
| EP2625561A4 (en) | Glasses | |
| GB2482354B (en) | Spectacles | |
| TWM386505U (en) | Glasses structure | |
| TWM390468U (en) | Eyeglasses | |
| AU333091S (en) | Glasses |